Who owns BOLT BIOTHERAPEUTICS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Bolt Biotherapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Bolt Biotherapeutics stock

Who bought or sold BOLT BIOTHERAPEUTICS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of
Novo A/S 4.5M $57M 0% Sep 2021
Vivo Capital 3.9M $49M 0% Sep 2021
Citadel Advisors 2.9M $37M -3% Sep 2021
FMR 2.8M $36M -1% Sep 2021
Sofinnova Ventures 2.8M $35M 0% Sep 2021
RA Capital Management 2.4M $30M 0% Sep 2021
Pivotal bioVenture Partners Investment Advisor 1.9M $24M 0% Sep 2021
Rock Springs Capital Management 1.6M $21M 2% Sep 2021
Suvretta Capital Management 1.3M $17M 39% Sep 2021
Nan Fung Group Holdings 1.2M $15M 0% Sep 2021
Holocene Advisors 1.2M $15M 7% Sep 2021

Setup an alert

Want to be notified whenever an investor makes a significant change to their holdings of Bolt Biotherapeutics?

Vanguard Group 993k $13M 54% Sep 2021
Samlyn Capital 742k $9.4M 100% Sep 2021
Samsara BioCapital 738k $9.3M 0% Sep 2021
Board of Trustees of The Leland Stanford Junior University 720k $9.1M 0% Sep 2021
Eventide Asset Management 534k $6.8M 0% Sep 2021
Goldman Sachs Group 443k $5.6M 100% Sep 2021
Woodline Partners 394k $5.0M 3% Sep 2021
Geode Capital Management 345k $4.4M 64% Sep 2021
State Street Corporation 281k $3.6M 34% Sep 2021
Ally Bridge Group 257k $3.3M -38% Sep 2021
Northern Trust 187k $2.4M 58% Sep 2021
Millennium Management 163k $2.1M 410% Sep 2021
EcoR1 Capital 150k $1.8M 0% Sep 2021
Rtw Investments 126k $1.6M 0% Sep 2021
Sectoral Asset Management 116k $1.5M -55% Sep 2021
DAFNA Capital Management 100k $1.3M 0% Sep 2021
Point72 Asset Management 94k $1.2M 100% Sep 2021
Nuveen Asset Management 91k $1.1M 68% Sep 2021
Endurant Capital Management 90k $1.1M 100% Sep 2021
Renaissance Technologies 79k $1.0M 31% Sep 2021
Bank of New York Mellon 71k $892k 51% Sep 2021
D. E. Shaw & Co 66k $829k 284% Sep 2021
Hambrecht & Quist Capital Management 65k $823k 100% Sep 2021
Charles Schwab Investment Management 52k $663k -32% Sep 2021
Ensign Peak Advisors 29k $366k 189% Sep 2021
Swiss National Bank 28k $354k 0% Sep 2021
DuPont Capital Management Corporation 27k $338k 100% Sep 2021
California State Teachers Retirement System 23k $294k 46% Sep 2021
Rhumbline Advisers 22k $271k 63% Sep 2021
Deutsche Bank Aktiengesellschaft 19k $244k 181% Sep 2021
Alpine Partners VI 19k $338k 100% Sep 2021
Qube Research & Technologies 15k $190k 100% Sep 2021
State of Wisconsin Investment Board 15k $190k 22% Sep 2021
Virtu Financial 15k $184k 100% Sep 2021
SG Americas Securities 14k $178k 100% Sep 2021
Virtus ETF Advisers 13k $165k -5% Sep 2021
Victory Capital Management 13k $161k 5% Sep 2021
American International 13k $158k 93% Sep 2021
Manufacturers Life Insurance Company 11k $139k 100% Sep 2021
MetLife Investment Advisors 9.5k $120k 100% Sep 2021
Cubist Systematic Strategies 7.2k $91k 100% Sep 2021
Metropolitan Life Insurance Company 7.2k $91k 100% Sep 2021
New York State Common Retirement Fund 4.5k $57k -61% Sep 2021
Legal & General Group 4.3k $55k 396% Sep 2021
S.A.C. Capital Advisors 2.1k $26k 100% Sep 2021
Summit Investment Advisors 1.8k $22k 70% Sep 2021
Tower Research Capital 687.00 $9.0k -58% Sep 2021
Advisor Group Holdings 638.00 $6.4k 155% Sep 2021
Northwestern Mutual Wealth Management Company 400.00 $5.0k 100% Sep 2021
UBS Group 265.00 $0 100% Sep 2021
Us Bancorp 235.00 $3.0k 100% Sep 2021
Signature 156.00 $2.0k 100% Sep 2021
Wells Fargo & Company 55.00 $999.999000 -65% Sep 2021
Ellevest 2.00 $0 100% Sep 2021

Who sold out of Bolt Biotherapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Franklin Resources Jun 2021 150k $2.3M
Nantahala Capital Management Jun 2021 50k $773k
Boxer Capital Jun 2021 50k $773k
Maven Securities Jun 2021 25k $390k
Prudential Financial Jun 2021 20k $311k
Two Sigma Investments Jun 2021 12k $190k
Parallel Advisors Sep 2021 82.00 $999.998200